Skip to main content


Figure 1 | Arthritis Research & Therapy

Figure 1

From: Renal co-morbidity in patients with rheumatic diseases

Figure 1

Algorithm for screening and monitoring of renal co-morbidity in rheumatic disease patients. See text for details. 1)Regular screening may be performed on a 6-monthly to 12-monthly basis. CKD, chronic kidney disease; eGFR, estimate glomerular filtration rate; MTX, methotrexate; NSAID, nonsteroidal anti-inflammatory drug; UTI, urinary tract infection.

Back to article page